EMC
53
-3
BK
72
-2
EXR
59
4
MS
80
-3
FOX
57
-3
CTSH
65
-3
VNO
60
8
PDCO
30
-6
DFS
67
-3
SWK
56
-6
LOW
58
2
CMI
67
4
IP
70
-3
EQR
60
6
CI
52
-7
EMR
77
-2
DOV
73
4
SIG
47
-2
PWR
71
-3
NI
73
3
EMC
53
-3
BK
72
-2
EXR
59
4
MS
80
-3
FOX
57
-3
CTSH
65
-3
VNO
60
8
PDCO
30
-6
DFS
67
-3
SWK
56
-6
LOW
58
2
CMI
67
4
IP
70
-3
EQR
60
6
CI
52
-7
EMR
77
-2
DOV
73
4
SIG
47
-2
PWR
71
-3
NI
73
3
Financhill
Back

Dr Reddy's Laboratories 10K Form

Buy
53

RDY
Dr Reddy's Laboratories

Last Price:
14.25
Seasonality Move:
2.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RDY News And Ratings

See the #1 stock for the next 7 days that we like better than RDY

RDY Financial Statistics

Sales & Book Value

Annual Sales: $3.37B
Cash Flow: $16.69M
Price / Cash Flow: 121.97
Annual Sales: $4.38
Price / Book: 3.37

Profitability

EPS (TTM): 0.46660
Net Income (TTM): $651.82M
Gross Margin: $1.98B
Return on Equity: 19.35%
Return on Assets: 14.21%

Dr Reddy's Laboratories Earnings Forecast

Key Dr Reddy's Laboratories Financial Ratios

  • The Gross Profit Margin over the past 24 years for RDY is 58.61%.
  • The Selling, General & Administrative Expenses for RDY have been equal to 27.65% of Gross Profit Margin.
  • The Research & Development expenses have been 8.19% of Revenue.
  • The Interest Expense is 3.07% of Operating Income.
  • The Net Earning history of RDY is 19.95% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 14 years.

Dr Reddy's Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RDY
CUSIP: 256135
Website: drreddys.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 1.92
Quick Ratio: 1.28

Price-to-Earnings

Trailing P/E Ratio: 18.3
Forward P/E Ratio: 18.58

RDY Technical Analysis vs Fundamental Analysis

Buy
53
Dr Reddy's Laboratories (RDY) is a Buy

Is Dr Reddy's Laboratories a Buy or a Sell?